Invisalign System
Align Technology, Inc. · Decision date Sep 25, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 25, 2026 for the Invisalign System, submitted by Align Technology, Inc. under K262196, a traditional 510(k) received June 29, 2026. The device is classified under 21 CFR 872.5470 with product codes PNN and NXC, in the dental specialty. SESE denotes clearance rather than premarket approval.
The submission describes a modification to the cleared predicate Invisalign System (K252380): an optional AI-enabled prediction service added to the backend 3D treatment planning software to support aligner activation design. The summary states no change to intended use, indications, aligner design or the end-to-end user workflow, and that the AI model is static and non-adaptive with no direct user interaction. The summary reports software verification and validation and performance validation meeting pre-specified acceptance criteria; detailed results and subgroup analyses are not in the public excerpts, so their magnitude remains unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262196
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Align Technology, Inc.
- Product code
- PNN
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Orthodontic Software.
- Applicant
- Align Technology, Inc.
- Product code
- PNN
- FDA device class
- 2
FDA decision timeline
K262196 received
Application receipt date recorded by FDA.
K262196 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PNN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LuxDesignK260421 | LuxCreo, Inc. | 510(k) clearance | Oct 23, 2026 | FDA |
Dr.AlignNaviK262378 | InnoDtech, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Align Technology, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Jose, CA
Sources and methodology
- Original FDA record: K262196
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
